Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Leishmania
100%
Nanophosphors
100%
Lateral Flow Assay
100%
Smartphone
100%
Recombinase Polymerase Amplification
100%
Limit of Detection
22%
Early Diagnosis
22%
Isothermal Amplification
22%
Molecular Diagnostics
11%
Improved Outcomes
11%
Clinical Outcomes
11%
Polymerase Chain Reaction
11%
Gold Nanoparticles
11%
Highly Sensitive
11%
Effective Treatment
11%
High Specificity
11%
High Sensitivity
11%
Diagnostic Tool
11%
Economic Outcomes
11%
Point-of-care Diagnostics
11%
Infectious Disease Surveillance
11%
Blue-emitting
11%
Vector-borne Disease
11%
Reduced Volume
11%
Low-resource Settings
11%
Amplification Method
11%
Point-of-care Diagnosis
11%
Persistent Luminescence
11%
Resource-limited Settings
11%
Smartphone-based
11%
Cutaneous Leishmaniasis
11%
Temperature Cycling
11%
Early Delivery
11%
Leishmania Panamensis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Lateral Flow Assay
100%
Recombinase
100%
Leishmania
100%
Diseases
11%
Infection
11%
Gold Nanoparticle
11%
Skin Leishmaniasis
11%
Pimeprofen
11%
Leishmania panamensis
11%
Immunology and Microbiology
Lateral Flow Assay
100%
Leishmania
100%
Polymerase Chain Reaction
11%
Infectious Disease
11%
Gene Amplification
11%
Cutaneous Leishmaniasis
11%
Leishmania panamensis
11%
Infection
11%